| Tumor |
Incidence |
Size |
Consistency |
Menstrual Irregularities |
Endocrine Effects |
Potential for Malignancy |
Special Remarks |
| Follicle cysts |
Rare in childhood; frequent in menstrual years; never in post-menopausal years |
< 6 cm, often bilateral |
Moderate |
Occasional |
Occasional anovulation with persistently proliferative endometrium |
None |
Often disappear after a 2-month regimen of oral contraceptives |
| Corpus luteum cysts |
Occasional, in menstrual years |
4-6 cm, unilateral |
Moderate |
Occasional delayed period |
Prolonged secretory phase |
None |
Functional cysts. Intraperitoneal bleeding occasionally |
| Theca lutein cysts |
Occurs with hydatidiform mole, choriocarcinoma; also with gonadotropin or clomiphene therapy |
To 4-5 cm, multiple, bilateral. (Ovaries may be = 20 cm in diameter.) |
Tense |
Amenorrhea |
hCG elevated as a result of trophoblastic proliferation |
None |
Functional cysts. Hematoperitoneum or torsion of ovary may occur. Surgery is to be avoided. |
| Inflammatory (tubo-ovarian abscess) |
Concomitant with acute salpingitis |
To 15-20 cm, often bilateral |
Variable, painful |
Menometrorrhagia |
Anovulation usual |
None |
Unilateral removal indicated if possible |
| Endometriotic cysts |
Never in preadolescent or postmenopausal years. Most common in women aged 20-40 years |
To 10-12 cm, occasionally bilateral |
Moderate to softened |
Rare |
None |
Very rare |
Associated pelvic endometriosis. Medical treatment or conservative surgery recommended |
| Teratoid tumors: |
| Benign teratomas (dermoid cysts) |
Childhood to post-menopause |
< 15 cm; 15% are bilateral |
Moderate to softened |
None |
None |
Rare |
Torsion can occur. Partial oophorectomy recommended |
| Malignant teratomas |
< 1% of ovarian tumors. Usually in infants and young adults |
> 20 cm, unilateral |
Irregularly firm |
None |
Occasionally, hCG elevated |
All |
Unresponsive to any therapy |
| Cystadenoma, cyst-adenocarcinoma |
Common in reproductive years |
Serous: < 25 cm, 33% bilateral; mucinous: up to 1 cm, 10% bilateral |
Moderate to softened |
None |
None |
> 50% for serous, about 5% for mucinous |
Peritoneal implants often occur with serous, rarely with mucinous. If mucinous tumor is ruptured, pseudomyxoma peritonei may occur. |
| Endometrioid carcinoma |
15% of ovarian carcinomas |
Moderate, 13% bilateral |
Firm |
None |
None |
All |
Adenocarcinoma of endometrium coexists in 15-30% of cases |
| Fibroma |
< 5% of ovarian tumors |
Usually < 15 cm |
Very firm |
None |
None |
Rare |
Ascites in 20% (rarely, pleural fluid) |
| Arrhenoblastoma |
Rare. Average age 30 years or more |
Often small (< 10 cm), unilateral |
Firm to softened |
Amenorrhea |
Androgens elevated |
< 20% |
Recurrences are moderately sensitive to irradiation |
| Theca cell tumor (thecoma) |
Uncommon |
< 10 cm, unilateral |
Firm |
Occasional irregularity |
Estrogens or androgens elevated |
< 1% |
|
| Granulosa cell tumor |
Uncommon. Usually in prepubertal girls or women older than 50 years |
May be very small |
Firm to softened |
Menometrorrhagia |
Estrogens elevated |
15-20% |
Recurrences are moderately sensitive to irradiation |
| Dysgerminoma |
About 1-2% of ovarian tumors |
< 30 cm, bilateral in 33% |
Moderate to softened |
None |
- |
All |
Very radiosensitive |
| Brenner tumor |
About 1% of ovarian tumors |
< 30 cm, unilateral |
Firm |
None |
- |
Very rare |
> 50% occur in postmenopausal years |
| Secondary ovarian tumors |
10% of fatal malignant disease in women |
Varies; often bilateral |
Firm to softened |
Occasional |
Very rare (thyroid, adrenocortical origin) |
All |
Bowel or breast metastases to ovary common |